explore -WSS

explore

author：hotspot 2025-10-02 20:52:18 - browse：347

Richard Neal. -- health policy coverage from STAT — Rep. Richard Neal (D-Mass.) Drew Angerer/Getty Images

WASHINGTON — A rift between Democrats and Republicans over health care transparency was on full display in the House on Wednesday.

Republicans on the House Ways & Means Committee introduced a package this week that they say would increase health care transparency, but Democrats and outside groups are arguing that it doesn’t go far enough to force companies to disclose information about their ownership. They also think it goes too easy on the private equity firms that are buying up health care practices.

“There was an opportunity here for bipartisanship, but I think we ought to reference that in the past tense,” said ranking Democrat Richard Neal (D-Mass.).

Unlock this article by subscribing to STAT+ and enjoy your first 30 days free!

GET STARTED Log In

Previous article： New air purifier tech could be key to improving indoor air quality
Next article： The future of health care in the House

entertainment

WSS

When women are denied an abortion, their children fare worse than peers

FDA panel signals lack of confidence in Amgen cancer drug data

What to expect at HLTH 2023, the health care industry conference

When women are denied an abortion, their children fare worse than peers

Why H5N1 bird flu is keeping the CDC's top flu scientist awake

Liquid biopsy for lung cancer is launched by Delfi

knowledge

explore

hotspot

New air purifier tech could be key to improving indoor air quality

Chan Zuckerberg Biohub Chicago to focus on inflammation

Virginia high school admissions case could be legal follow

Adam's Biotech Scorecard: PDS Biotech's survival benefit is overstated

After affirmative action ruling, medical educators look to 'holistic review'

STAT series 'Denied by AI' wins major journalism prizes

Malaria cases in Florida and Texas: Here’s what you need to know

Novo Nordisk testing Wegovy against alcohol

Anesthesiologist group: stop taking Ozempic before surgery

A Q&A with the global head of Boehringer Ingelheim's innovation unit

focus

Histogen: Failed biotech offers rare public look inside

The White House hikes tariffs on plastic syringes made in China

AI can decode, harness the power of the humane immune system

3 questions for the future of Biden's cancer moonshot

Supreme Court to hear if Covid misinformation is protected speech

VC firm General Catalyst wants to buy a health system

entertainment

entertainment

entertainment

leisure time